Klümper, N., Wüst, L., Saal, J., Ralser, D. J., Zarbl, R., Jarczyk, J., . . . Eckstein, M. PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma. Taylor & Francis Group.
Chicago Style (17th ed.) CitationKlümper, Niklas, et al. PD-L1 (CD274) Promoter Hypomethylation Predicts Immunotherapy Response in Metastatic Urothelial Carcinoma. Taylor & Francis Group.
MLA (9th ed.) CitationKlümper, Niklas, et al. PD-L1 (CD274) Promoter Hypomethylation Predicts Immunotherapy Response in Metastatic Urothelial Carcinoma. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.